Welcome to Hologic Investor Relations

Hologic, Inc. is an innovative medical technology company primarily focused on improving women's health and well-being through early detection and treatment.

The Company's Common Stock is listed on the Nasdaq Global Select Market under the trading symbol HOLX.

Recent and Upcoming Events
Recent News
Nov 24, 2017

Hologic, Inc. (Nasdaq: HOLX) announced today that it has received 510(k) clearance from the United States Food and Drug Administration (FDA) for its Quantra™ 2.2 Breast Density Assessment...

Nov 14, 2017

Hologic, Inc. (Nasdaq: HOLX) announced today that holders of the 2.00% Convertible Senior Notes due 2043 (CUSIP No. 436440 AG6) issued February 21, 2013 have the right to surrender their notes for...

Nov 8, 2017

Hologic, Inc. (Nasdaq: HOLX) announced today the Company's financial results for the fiscal fourth quarter ended September 30, 2017. Revenue of $802.9 million increased 10.5%, or 9.9% in constant...

Nov 6, 2017

Hologic, Inc. (Nasdaq: HOLX) announced today that the Company will present at these upcoming investor conferences: The Stifel 2017 Healthcare Conference in New York, NY on Tuesday, November 14 at...

More ›